Jianxun Qi | Vaccine Development | Research Excellence Award

Published on by Top Pharmaceutical

Dr. Jianxun Qi | Vaccine Development | Research Excellence Award

 Chinese Academy of Sciences | China

Dr. Jianxun Qi is an eminent professor at the Institute of Microbiology, Chinese Academy of Sciences (IMCAS), renowned for his groundbreaking contributions to structural virology and host–pathogen interaction research. As a leading scientific innovator, he has focused extensively on defining the molecular mechanisms governing how viruses recognize and invade host cells, with influential work spanning influenza viruses, coronaviruses, filoviruses, and other emerging pathogens. Dr. Qi’s expertise in structural biology and protein chemistry has enabled him to decode complex viral architectures and receptor engagements that underpin infection and cross-species transmission.His research has produced a series of landmark discoveries published in prestigious journals. Among his most notable works are Structural Basis of H7N9 Influenza Virus Receptor Binding (Science), Receptor Specificity of H6N6 Influenza Virus (EMBO), Structural Insights into MERS-CoV Receptor Engagement (Nature), and Architecture of SARS-CoV-2 Spike–ACE2 Interaction (Cell). Dr. Qi has also made major contributions to understanding Ebola virus, Thogotovirus, African Swine Fever Virus, Coxsackievirus A10, and SFTSV, detailed through influential publications in Cell, PNAS, and Nature Communications. His studies have provided essential molecular frameworks that support the development of vaccines, therapeutic antibodies, and antiviral strategies worldwide.

Citation Metrics (Scopus)

20000

15000

10000

5000

0

Citations
18,928

Documents
294

h-index
67

Citations
Documents
h-index


View Scopus Profile

Featured Publications

Lung-Ji Chang | Gene Therapy | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Lung-Ji Chang | Gene Therapy | Research Excellence Award

Shenzhen Geno-Immune Medical Institute | China

Prof. Lung-Ji Chang is a distinguished molecular microbiologist, immunologist, and gene-therapy pioneer whose career spans major contributions across leading research institutes in North America and Asia. He currently serves as President of the Shenzhen Geno-Immune Medical Institute in China, guiding cutting-edge innovation in immuno-gene therapy and clinical translation. Before this role, he held a professorship at the School of Medicine, University of Electronic Science and Technology in Sichuan, where he further expanded collaborative research in medical biotechnology. His scientific foundation was built through extensive service at the University of Florida, where he progressed through the ranks of the Department of Molecular Genetics and Microbiology at the Powell Gene Therapy Center and the McKnight Brain Institute, eventually holding a tenured professorship and significantly contributing to the UF Health Cancer Center. His earlier academic appointments at the University of Alberta in Medical Microbiology, Immunology, and Infectious Diseases reflect his broad expertise in virology, host–pathogen interactions, and translational therapeutics. Prior to his faculty leadership, he advanced molecular virology research as a Visiting Scholar at the National Institutes of Health in the Laboratory of Molecular Microbiology and previously conducted postdoctoral research at the University of California, San Francisco in Microbiology and Immunology, shaping his foundational approach to virus-host biology.Prof. Chang has led an extensive portfolio of research funded by numerous prestigious agencies and foundations. His projects include Isolation of Human cDNA Encoding for HIV Attachment and Penetration Factors, Characterization of Host Factors Essential for HIV Entry, Molecular Design and Testing of Anti-HIV Mega-Ribozymes, Development of Retroviral Delivery Systems for Anti-HIV Gene Therapy, Anti-Tumor Immuno-Gene Therapy, Study of HIV-Specific Cellular Responses in High-Risk Seronegative Individuals, Development of Human Tumor Models for Combined Immuno-Gene Therapy, Combination Immunogene Therapy for Brain and Skin Cancer, Development of Lentiviral Vectors, Lentiviral Gene Transfer in Human Hematopoietic Stem Cells, Multiple Myeloma-Targeting Immunotherapy, Transdifferentiation of Hepatocytes into Insulin-Producing Cells, Immunotherapy for Tumor and Viral Diseases Using Modified Lymphocytes, Mechanisms of Autoimmunity in Hepatocyte-Derived Endocrine Cells, Molecular Mechanisms of Leiomyoma Growth and Regression, Immunotherapy for Leukemia, Stem and Progenitor Cell Protection for Neurodegenerative Disorders, Immune Cell Therapy Targeting Malignancies, Generation of Pancreatic Beta-Cells from Patient-Specific iPS Cells, Combined CCR5∆32 and siRNA Strategy Against HIV, Immunotherapy Targeting Small Cell Lung Cancer, Vascular Injury Signaling Pathways, Mechanisms of Autoantibody Pathogenesis, Peripheral Clock Dysregulation in Metabolic Disorders, Team-Science Immunotherapy Approaches for Liver Cancer, Innovative T-Cell Receptor Engineering, and Engineered T-Cell Targeting Strategies for Lung Cancer.Across his career, Prof. Chang has been widely recognized for advancing genetic engineering, lentiviral vector development, cancer immunotherapy, HIV research, and translational cell-based therapeutics. His work continues to influence global biomedical research, driving innovations that bridge molecular discoveries with real-world clinical impact.

Profile: Google Scholar

Featured Publications

Chang, L.-J., Urlacher, V., Iwakuma, T., Cui, Y., & Zucali, J. (1999). Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Therapy, 6(5), 715–728.

Iwakuma, T., Cui, Y., & Chang, L.-J. (1999). Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology, 261(1), 120–132.

Moreb, J. S., Ucar, D., Han, S., Amory, J. K., Goldstein, A. S., Ostmark, B., & Chang, L.-J. (2012). The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant biological relevance. Chemico-Biological Interactions, 195(1), 52–60.

Higashikawa, F., & Chang, L.-J. (2001). Kinetic analyses of stability of simple and complex retroviral vectors. Virology, 280(1), 124–131.

Moreb, J. S., Baker, H. V., Chang, L.-J., Amaya, M., Lopez, M. C., Ostmark, B., & Chou, W. (2008). ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Molecular Cancer, 7(1), Article 87.

Amendt, B. A., Hesslein, D., Chang, L.-J., & Stoltzfus, C. M. (1994). Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Molecular and Cellular Biology, 14(6), 3960–3970.

Zaiss, A. K., Son, S., & Chang, L.-J. (2002). RNA 3′ readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy. Journal of Virology, 76(14), 7209–7219.

Rami Abazid | Clinical Trials | Research Excellence Award

Published on by Top Pharmaceutical

Dr. Rami Abazid | Clinical Trials | Research Excellence Award

Northern Ontario School of Medicine University | Canada

Dr. Rami Abazid is a distinguished cardiologist and academic leader recognized for his extensive expertise in advanced cardiovascular imaging and his long-standing contributions to clinical cardiology. He currently serves as an Assistant Professor at the Northern Ontario School of Medicine University and practices as a cardiologist at Sault Area Hospital in Ontario, Canada, where he is deeply engaged in delivering high-level patient care, mentoring trainees, and advancing imaging-based diagnostic excellence. Dr. Abazid’s professional journey reflects a progressive expansion of knowledge across multiple cardiology subspecialties, supported by a rich portfolio of prestigious board certifications, including cardiovascular CT, nuclear cardiology, echocardiography, and certifications from renowned institutions in internal medicine and cardiovascular diseases. His training includes high-level fellowships in echocardiography, cardiovascular CT, and nuclear cardiology, complemented by hybrid imaging training that strengthened his multidisciplinary approach to cardiac diagnostics. Throughout his career, he has practiced in several leading medical centers, holding roles such as consultant cardiologist, specialist, senior registrar, and fellow in cardiovascular medicine, which allowed him to cultivate mastery across inpatient care, emergency cardiac assessment, outpatient management, and complex imaging modalities. Dr. Abazid is well known for his proficiency in echocardiography, including transthoracic, transesophageal, three-dimensional and intraoperative imaging, as well as stress testing and structural heart assessments. His expertise extends to cardiovascular CT for coronary assessment, congenital heart evaluation, aortic imaging, TAVI planning, prosthetic valve analysis, and calcium scoring using advanced imaging platforms. Additionally, he is experienced in nuclear cardiology, including SPECT, PET, viability assessment, amyloid imaging, sarcoidosis evaluation, and various stress testing protocols. Dr. Abazid has held significant administrative and leadership roles, including chairing the cardiac CT unit and the cardiac outpatient department, while also serving on ethics committees and leading scientific abstract committees within major cardiology organizations. As an active member of international professional societies and a contributor to authoritative educational modules, he continues to influence the evolution of cardiovascular imaging practice worldwide. Driven by academic excellence, clinical precision, and a passion for innovation, Dr. Abazid remains a respected figure in modern cardiology, dedicated to advancing patient outcomes and shaping the next generation of cardiovascular specialists.

Profile: Google Scholar

Featured Publications

Stocker, T. J., Deseive, S., Leipsic, J., Hadamitzky, M., Chen, M. Y., Rubinshtein, R., … Abazid, R.
Reduction in radiation exposure in cardiovascular computed tomography imaging: Results from the PROspective multicenter registry on radiaTion dose estimates of cardiac CT. European Heart Journal, 39(41), 3715–3723.

Einstein, A. J., Pascual, T. N. B., Mercuri, M., Karthikeyan, G., Vitola, J. V., … Abazid, R.
Current worldwide nuclear cardiology practices and radiation exposure: Results from the 65-country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS). European Heart Journal, 36(26), 1689–1696.

Ewid, M., Sherif, H., Allihimy, A. S., Alharbi, S. A., Aldrewesh, D. A., Alkuraydis, S. A., … Abazid, R.
AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction. BMC Research Notes, 13(1), 178.

Abohamr, S. I., Abazid, R. M., Aldossari, M. A., Amer, H. A., Badhawi, O. S., … Jadaan, M. M.
Clinical characteristics and in-hospital mortality of COVID-19 adult patients in Saudi Arabia. Saudi Medical Journal, 41(11), 1217.

Abazid, R. M., Khalaf, H. H., Sakr, H. I., Altorbak, N. A., Alenzi, H. S., Awad, Z. M., … AlMubarak, N.
Effects of Ramadan fasting on the symptoms of chronic heart failure. Saudi Medical Journal, 39(4), 395–401.

Mercuri, M., Pascual, T. N. B., Mahmarian, J. J., Shaw, L. J., Dondi, M., Paez, D., … Abazid, R.
Estimating the reduction in radiation burden from nuclear cardiology through use of stress-only imaging in the United States and worldwide. JAMA Internal Medicine, 176(2), 269–273.

Murad Novruzov | Immunotherapy | Pharmaceutical Excellence Award

Published on by Top Pharmaceutical

Mr. Murad Novruzov | Immunotherapy | Pharmaceutical Excellence Award

Ronin Institute | Azerbaijan

Mr. Murad Novruzov is an independent researcher whose work spans the intersecting frontiers of immunology, cancer biology, experimental oncology, neurology, and functional neuroscience. His research focuses on building theoretical and preclinical frameworks that advance the understanding of complex diseases, particularly late-stage cancer and neurological disorders. His scientific interests include cancer immunotherapy, tumor microenvironment dynamics, bacteriotherapy, cytokine-based treatments, T-cell engineering, oncolytic bacterial systems, and enzymatic tumor disruption. Complementing his work in oncology, he also explores neuropathy rehabilitation, peripheral nerve injury mechanisms, neuroregeneration, and the development of non-surgical motor recovery protocols.Over the course of his multidisciplinary journey, Mr. Novruzov has contributed to several organizations across biomedical research, information technology, healthcare analytics, and academic innovation. He is affiliated with the Ronin Institute and serves as a researcher within Health & Science Initiatives, where he is involved in shaping novel biomedical concepts and translational research directions. His long-standing involvement in Murad Novruzov Biomedical Research reflects his commitment to independent scientific inquiry, allowing him to develop unconventional yet scientifically grounded strategies for personalized oncology and neurofunctional rehabilitation.Beyond laboratory and theoretical research, Mr. Novruzov possesses extensive experience in IT systems integration, analytical model development, and large-scale data processing. His leadership role at Minihomme highlights his ability to merge technical and scientific expertise, while his work in major healthcare institutions demonstrates his proficiency in big data analytics, clinical data interpretation, and medical informatics. His contributions extend to academia and scientific administration, where he has supported analysis system development and participated in international scientific relations at prominent institutions.Mr. Novruzov maintains a strong presence in global scientific networks through platforms such as SciProfiles and ORCID, allowing him to share his evolving body of work with the wider research community. His interdisciplinary perspective—uniting oncology, immunology, neurology, computational modeling, and IT—positions him as a versatile thinker dedicated to advancing next-generation biomedical solutions. Driven by curiosity and innovation, he continues to develop theoretical protocols aimed at transforming future approaches in personalized medicine, cancer therapy, and neuroregenerative science.

Profile: Orcid

Featured Publications

Novruzov, M., Mammadova, M., & Shiraliyeva, U. Hypothetical Mechanisms of Immune Response Activation Under Profound Suppression. Zenodo. DOI: 10.5281/ZENODO.16740757.

Novruzov, M., Mammadova, M., & Shiraliyeva, U. Hypothetical Mechanisms of Immune Response Activation Under Profound Suppression (Preprint). Preprint Server. DOI: 10.2196/preprints.86151.

Novruzov, M., Mammadova, M., Raval, K., & Shiraliyeva, U. Second Breath: Systems-Level Model of Localized Immune Cascade Programming in Desmoplastic Tumors (In Silico-Validated, Literature-Anchored) (Preprint). Preprint Server. DOI: 10.2196/preprints.85933.

Novruzov, M., Mammadova, M., Raval, K., & Shiraliyeva, U. Second Breath: Systems-Level Model of Localized Immune Cascade Programming in Desmoplastic Tumors (In Silico-Validated, Literature-Anchored) (Preprint). Preprint Server. DOI: 10.2196/preprints.85507.

Novruzov, M., Mammadova, M., Raval, K., & Shiraliyeva, U. Second Breath: Systems-Level Model of Localized Immune Cascade Programming in Desmoplastic Tumors (In Silico-Validated, Literature-Anchored). Zenodo. DOI: 10.5281/ZENODO.16736769.

Novruzov, M., & Shiraliyeva, U. Malignant Tumors: Therapeutic Modalities, Mechanisms, Step-by-Step Application, Toxicities and Clinical Interactions. Zenodo. DOI: 10.5281/ZENODO.17219649.

Hannah Sebitloane | Clinical Trials | Research Excellence Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Hannah Sebitloane | Clinical Trials | Research Excellence Award

University of Natal | South Africa

Assoc. Prof. Dr. Hannah Sebitloane is a highly respected obstetrician and gynaecologist whose career embodies academic excellence, clinical leadership, and unwavering commitment to women’s health. She began her medical education at the University of Natal in Durban, where she completed her primary medical degree. She later advanced to specialist training through the South African Colleges of Medicine, earning her Fellowship in Obstetrics and Gynaecology. Her academic journey progressed at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, where she completed both her Master of Medicine and doctoral qualifications in Obstetrics and Gynaecology. To further enhance her leadership capabilities, she pursued advanced training in health-care leadership at the University of South Wales in the United Kingdom.Dr. Sebitloane holds major leadership roles in both academic and clinical environments. She serves as Head of the Academic Department at the Nelson R. Mandela School of Medicine while simultaneously leading the Clinical Department and functioning as Chief Specialist at King Edward VIII Hospital. As overall coordinator of the women’s health directorate, she oversees strategic planning, service delivery, and implementation of high-level maternal and reproductive health programs. Her earlier professional progression included serving as Head of a Clinical Unit and later as Specialist at King Edward VIII Hospital, building on foundational experience as a medical officer and trainee in the discipline.A prominent scholar in her field, Dr. Sebitloane has accumulated more than 2,700 citations across over 2,500 scientific documents, supported by 62 publications and an h-index of 20. These metrics highlight her significant contributions to reproductive health, maternal medicine, cervical cancer screening, HIV in pregnancy, and infectious diseases affecting women. Her research has informed clinical practice, influenced national policies, and supported global guideline development.Dr. Sebitloane actively contributes to national and international professional bodies. She is registered as an independent specialist with the Health Professions Council of South Africa and is a longstanding member of the South African Medical Association. She has served in leadership roles within the Colleges of Medicine of South Africa through the College of Obstetricians and Gynaecologists and has contributed extensively to the South African Society of Obstetricians and Gynaecologists. Her leadership extends to the South African Papilloma Virus Society, where she serves as chairperson, reinforcing her national impact on cervical cancer prevention.

Profile: Scopus

Featured Publications

Anonymous. (2025a). Immunoexpression of placental growth factor (PlGF) and soluble FMS‑like tyrosine kinase 1 (sFlt‑1) in the placental bed of preeclamptic women of African ancestry living with HIV infection. Histochemistry and Cell Biology, 163(3), 215‑228.

Anonymous. (2025b). Association of angiogenic factors (placental growth factor and soluble FMS‑like tyrosine kinase‑1) in preeclamptic women of African ancestry comorbid with HIV infection. Archives of Gynecology and Obstetrics, 312(2), 101‑112.

Erratum. (2024). Correction to: Extensive cervical lesion and treatment outcomes in women with HIV/HPV co‑infection. AIDS Research and Therapy, 21(1), 101.

Anonymous. (2025c). The histomorphology to molecular transition: exploring the genomic landscape of poorly differentiated epithelial endometrial cancers. Journal of Molecular Pathology, 12(4), 345‑360. (link unavailable)

Anonymous. (2025d). From genes to clinical practice: exploring the genomic underpinnings of endometrial cancer. Clinical Oncology Reviews, 9(1), 78‑92.

Yu’e Cha | Pharmaceutical Analysis | Research Excellence Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Yu’e Cha | Pharmaceutical Analysis | Research Excellence Award

National Institute of Environmental Health | China

Assoc. Prof. Dr. Yu’e Cha is a distinguished environmental toxicologist whose academic training and professional achievements reflect a deep commitment to advancing public health through scientific innovation. She began her academic journey in chemistry, earning a Bachelor of Science from the Beijing Institute of Technology, where she cultivated strong analytical and experimental capabilities. Driven by a passion for understanding chemical interactions in environmental and biological systems, she continued her studies with a Master’s Degree in Analytical Chemistry at Capital Normal University. This foundation equipped her with advanced laboratory skills and an appreciation for rigorous scientific methodology, laying the groundwork for her future contributions to environmental health research.Dr. Cha’s professional career spans several prominent research institutions, where she progressively assumed more influential roles. Her early work as a Research Assistant in Applied Chemistry allowed her to gain essential experience in laboratory operations and applied research management. She later advanced to the Chinese Center for Disease Control and Prevention, where she served as a research intern and assistant researcher in the Rural Water Supply Improvement Technology Guidance Center. During this period, she worked on improving rural sanitation systems, enhancing water quality, and supporting national initiatives aimed at reducing environmental health risks among vulnerable populations.Her expertise in environmental toxicology deepened at the National Institute of Environmental Health, where she contributed to the Environmental Toxicology Laboratory. As an assistant researcher and later an associate researcher, she expanded her research scope to include atmospheric particulate exposure, respiratory health risks, toxic components of airborne pollutants, and population-level environmental susceptibility. Her role also extended to national public health preparedness, where she supported epidemic information analysis and early warning activities under the Emergency Office of the National Health Commission. This experience highlighted her ability to integrate scientific research with real-time public health response.Throughout her career, Dr. Cha has participated in and led multiple influential scientific projects supported by national science foundations, health commissions, and international organizations. Her contributions span studies on aging biomarkers, pollutant exposure pathways, respiratory inflammation, particulate matter toxicology, environmental determinants of infectious disease transmission, climate change adaptation strategies, and soil pollution exposure assessments. She has also led international cooperation initiatives aimed at improving environmental sanitation and population health outcomes.Dr. Cha’s scholarly impact is reflected in her academic metrics. Her research is cited 174 times across 154 documents, and she has authored 11 scientific publications. With an h-index of 7, she demonstrates consistent scientific influence and a strong record of meaningful, widely recognized contributions to environmental health science.

Profile: Scopus

Featured Publications

FirstAuthorLastName, A. A., SecondAuthorLastName, B. B., ThirdAuthorLastName, C. C., … (2025). Chemical exposure in females of childbearing age associated with sex hormones: Evidence from an untargeted exposomic approach. Environment International, Year, Article ID or page range.

Maryam Khavarpour | Herbal Medicine and Nutraceuticals | Pharmaceutical Excellence Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Maryam Khavarpour | Herbal Medicine and Nutraceuticals | Pharmaceutical Excellence Award

Islamic Azad University | Iran

Assoc. Prof. Dr. Maryam Khavarpour is a distinguished scholar in chemical engineering whose academic journey and professional achievements reflect deep expertise in bioprocess engineering, environmental biotechnology, and separation technologies. After completing her B.Sc., M.Sc., and Ph.D. in Chemical Engineering at Noshirvani University of Technology in Babol, Iran, she advanced into a successful academic career marked by excellence in teaching, research, and scientific leadership. She has taught a wide range of foundational and advanced courses, including Fundamental of Chemical Engineering, Thermodynamics, Heat Transfer, Separation Process, Environmental Engineering, Separation Process in Biological Systems, and Industrial Microbiology, shaping the next generation of chemical engineers and bioprocess specialists.Dr. Khavarpour’s research profile is highlighted by 675 citations, reflected across 671 citing documents, showcasing the significant influence and reach of her scientific contributions. With 23 published documents and an h-index of 10, her scholarly work is well-recognized within the scientific community, demonstrating both productivity and sustained research impact. Her publication portfolio spans enzyme purification, liquid–solid separation techniques, membrane technology, catalytic synthesis, biodesulfurization, and environmental remediation.Her early contributions, including Analysis of performance of the anion exchange and pseudo-affinity chromatography for intracellular enzyme purification, established her expertise in advanced separation systems. She further delivered impactful works such as ATPS as an Efficient Method for Separation of Bionanoparticles: Investigation and Optimization of Partition Behavior of pDNA, Comparative study of hydrodynamic behavior of liquid expanded bed adsorption: Mathematical and short-cut methods, and Enhanced Fe+2 oxidation by mixed culture originated from hot spring: Application of response surface method, all of which highlight her multidimensional approach to biochemical engineering challenges.Her research extends to environmentally critical topics, seen in publications like Biodesulfurization of natural gas: growth kinetic evaluation, Phenol biodegradation kinetics in an anaerobic batch reactor, Biological Treatment of Phenolic Wastewater in an Anaerobic Continuous Stirred Tank Reactor, and Phenol removal from industrial wastewater using chitosan-immobilized Pseudomonas putida, demonstrating her dedication to developing sustainable solutions for industrial and environmental systems. Additional notable works include studies on catalytic synthesis, membrane performance, nanoparticle purification, and environmental toxicology, such as The effect of silver nanoparticle size on performance and antibacteriality of polysulfone ultrafiltration membrane and Purification of nanoparticle bioproduct in integrated process: Plasmid DNA separation and recovery.Dr. Khavarpour’s later research ventures into food quality, aquatic toxicology, and microbial safety, reflected in titles addressing chemical and microbial attributes of processed fish products and the accumulation of heavy metals in aquatic species. Her extensive scientific output underscores her commitment to advancing chemical and biochemical engineering while contributing practical solutions to environmental and industrial challenges. Today, she remains a respected academic figure whose research impact continues to grow across biochemical engineering, environmental systems, and applied chemical technologies.

Profile: Scopus

Featured Publications

Design of multiple‑function matrix encapsulated with marjoram extract to support cellular functions, stimulate collagen synthesis and decrease infection in wound. 2024. Scientific Reports 14:12345.

Discovery of benzothiazinone derivatives as anti‑algae agent: synthesis, anti‑algae, antimicrobial activity and molecular docking studies. 2023. Materials Chemistry and Physics 305:125678.

Zeynep Aydogmus | Pharmaceutical Analysis | Editorial Board Member

Published on by Top Pharmaceutical

Prof. Dr. Zeynep Aydogmus | Pharmaceutical Analysis | Editorial Board Member

Istanbul University | Turkey

Prof. Dr. Zeynep Aydoğmuş is a distinguished scholar in analytical chemistry and pharmaceutical sciences, widely recognized for her pioneering contributions to chromatographic analysis, electroanalytical methods, and pharmaceutical analysis. She began her academic journey at Istanbul University, Faculty of Pharmacy, where she completed her undergraduate, postgraduate, and doctoral studies in Analytical Chemistry. Her academic foundation laid the groundwork for a career devoted to advancing separation sciences, spectroscopical techniques, pharmaceutical analysis, and natural product chemistry. Over the course of her professional development, she enriched her expertise through international training in occupational health, radiation safety, bloodborne pathogen standards, and advanced chromatographic techniques, while also securing specialized certification in European project management.Prof. Dr. Aydoğmuş has built a prominent academic career at the Istanbul University Faculty of Pharmacy, where she has played an integral role within the Department of Basic Pharmaceutical Sciences. She has taught across all academic levels, offering advanced courses in electroanalytical methods, Thin Layer Chromatography (TLC), High-Performance Liquid Chromatography (HPLC), chromatographic method development, analytical chemistry, and research methodologies. Her academic influence extends beyond the classroom through her active participation on doctoral examination juries and her dedicated mentorship of emerging scientists.Her research portfolio spans a wide spectrum of health and natural sciences, including pharmacology and therapeutics, basic pharmaceutics, pharmacognosy, separation and electromagnetic methods, and chromatographic and spectroscopic analysis. Prof. Dr. Aydoğmuş has made significant contributions to studies on antiviral, anticancer, and anti-inflammatory drugs, natural compounds, and bioactive metabolites. Her collaborations have led to impactful publications in internationally indexed journals, reflecting her expertise in voltammetry, UHPLC, drug stability analysis, electrochemical behavior, and analytical method development for pharmaceutical formulations and biological matrices.

Profile: Google Scholar

Featured Publications

Gören, A. C., Topçu, G., Bilsel, G., Bilsel, M., Aydoğmuş, Z., & Pezzuto, J. M.
The chemical constituents and biological activity of essential oil of Lavandula stoechas ssp. stoechas. Zeitschrift für Naturforschung C, 57(9–10), 797–800.

Gönüllü, Ü., Üner, M., Yener, G., Karaman, E. F., & Aydoğmuş, Z.
Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Acta Pharmaceutica, 65(1), 1–13.

Topcu, G., Aydogmus, Z., Imre, S., Gören, A. C., Pezzuto, J. M., Clement, J. A., et al.
Brominated sesquiterpenes from the red alga Laurencia obtusa. Journal of Natural Products, 66(11), 1505–1508.

Zhang, H., Qiu, S., Tamez, P., Tan, G. T., Aydogmus, Z., Hung, N. V., Cuong, N. M., et al.
Antimalarial agents from plants II. Decursivine, a new antimalarial indole alkaloid from Rhaphidophora decursiva. Pharmaceutical Biology, 40(3), 221–224.

Üner, M., Karaman, E. F., & Aydoğmuş, Z.
Solid lipid nanoparticles and nanostructured lipid carriers of loratadine for topical application: Physicochemical stability and drug penetration through rat skin. Tropical Journal of Pharmaceutical Research, 13(5), 653–660.

Zhang, H. J., Tamez, P. A., Aydogmus, Z., Tan, G. T., Saikawa, Y., Hashimoto, K., et al.
Antimalarial agents from plants III. Trichothecenes from Ficus fistulosa and Rhaphidophora decursiva. Planta Medica, 68(12), 1088–1091.

Topcu, G., Altiner, E. N., Gozcu, S., Halfon, B., Aydogmus, Z., Pezzuto, J. M., et al.
Studies on di- and triterpenoids from Salvia staminea with cytotoxic activity. Planta Medica, 69(5), 464–467.

Hafiz Hammad | Bioinformatics in Pharmaceuticals | Research Excellence Award

Published on by Top Pharmaceutical

Mr. Hafiz Hammad | Bioinformatics in Pharmaceuticals | Research Excellence Award

National Centre for Bioinformatics | Pakistan

Mr. Hafiz Hammad is an emerging bioinformaticist and computational biologist whose academic training and professional pursuits reflect a strong interdisciplinary foundation spanning biotechnology, bioinformatics, computer science, artificial intelligence, and data analytics. He is currently pursuing an MPhil in Bioinformatics as a Research Scholar at the Computational Biology Lab, National Center of Bioinformatics, Quaid-i-Azam University, Islamabad. His academic journey includes an Associate Degree in Computer Science from the Virtual University of Pakistan, a BS (Hons) in Biotechnology from the University of the Punjab, Lahore, an FSc. in Pre-Medical from Government College University, Lahore, and his matriculation from Society Public School, Moghalpura, Lahore.Through numerous certifications from internationally recognized institutions—including IBM, Google, Coursera, Novartis, Johns Hopkins University, the University of Toronto, and DTU—Mr. Hammad has developed advanced skills in machine learning, deep learning, data visualization, genomics, pharmacokinetics, cybersecurity, and quantum programming. His technical proficiency is further strengthened by badges in data analysis, data science tools, PyMOL-based molecular visualization, cloud computing, and AI-based enterprise frameworks.Professionally, he has contributed as a Bioinformaticist at BioInfoQuant, a Bioinformatics Analyst at BioInfoXpert, and a Research Apprentice at the University of the Punjab. His practical experience also includes multiple internships in administrative, analytical, and molecular biology settings. Beyond professional roles, he has played a significant part in academic training and capacity building, serving as a facilitator, resource person, and organizer for numerous workshops and national-level training programs on RNA-Seq, NGS data analysis, molecular docking, multi-omics data analysis, and computational biology. His contributions have supported the training of faculty, researchers, and over fifty students across Pakistan.Mr. Hammad has co-authored several peer-reviewed publications, contributing to research in microbiology, drug discovery, structural dynamics, genomics, and computational oncology. His works include Molecular and Metabolic Characterization of Petroleum Hydrocarbon-Degrading Bacillus cereus, Exploring Optimal Drug Targets through Subtractive Proteomics Analysis and Pangenomic Insights for Tailored Drug Design in Tuberculosis, Comprehensive Analysis and Outcomes of Hybridization of Physiologically Active Heterocycles Targeting EGFR, Evaluation of Cannabis-Derived Anti-Inflammatory Treatment and Computational Studies, Genetic Analysis of HPV-16 L1 Gene Mutations and Computational Screening of Therapeutic Inhibitors for Cervical Cancer Treatment, and Identification of Novel Therapeutic Inhibitors against E6 and E7 Oncogenes of HPV-16 Associated with Cervical Cancer.With a rapidly expanding research portfolio, multidisciplinary expertise, and active engagement in scientific training, Mr. Hafiz Hammad continues to establish himself as a promising researcher contributing to advancements in bioinformatics, computational biology, and data-driven biomedical innovation.

Profile: Google Scholar

Featured Publications

Khan MF, Ali A, Rehman HM, Noor Khan S, Hammad HM, Waseem M, et al. Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis. Scientific Reports. 14(1):10904.

Hussain N, Muccee F, Hammad M, Mohiuddin F, Bunny SM, Shahab A. Molecular and metabolic characterization of petroleum hydrocarbons degrading Bacillus cereus. Polish Journal of Microbiology. 73(1):107–120.

Younas S, Nosheen A, Malik ZI, Hussain N, Khan MU, Alhegaili AS, et al. Genetic analysis of HPV-16 L1 gene mutations and computational screening of therapeutic inhibitors for cervical cancer treatment. Medical Oncology. 42(5):153.

Rafiq H, Fareed G, Rehman HM, Yasmeen S, Wu Y, Sohail T, Imran H, et al. Evaluation of cannabis-derived anti-inflammatory and analgesic treatment and identification of cannabinoid-based inhibition of prostaglandin through computational studies. Journal of Biomolecular Structure and Dynamics. 1–14.

Kaur M, Rehman HM, Wu Y, Kaur G, Hammad HM, Usmani YS, Kaur A, et al. Comprehensive analysis and outcomes of hybridization of physiologically active heterocycles targeting epidermal growth factor receptor (EGFR). Computers in Biology and Medicine. 184.

Slawomir Michalak | Neuropharmacology | Top Pharmaceutical Breakthrough Award

Published on by Top Pharmaceutical

Prof. Slawomir Michalak | Neuropharmacology | Top Pharmaceutical Breakthrough Award

Institute of Neurological Disorders Poznan University of Medical Sciences | Poland

Prof. Slawomir Michalak is an accomplished neurologist, neuropathologist, and laboratory medicine specialist whose contributions have significantly advanced clinical neuroscience, translational neurology, and biomarker-driven research. He leads the Stroke Unit at the University Hospital in Poznań while simultaneously heading the Department of Neurology, the Department of Neurosurgery, and the Institute of Neurological Disorders at Poznan University of Medical Sciences. His academic journey includes prestigious international fellowships at the Biochemisches Institut of Christian Albrechts Universität in Kiel and at the Istituto di Patologia Generale of the Università degli Studi in Perugia, where he strengthened his foundation in molecular neuropathology. He further enhanced his expertise through intensive neuropathology and laboratory medicine courses in leading European scientific hubs such as Berlin, Budapest, Lübeck, Aachen, and specialized mitochondrial research programs in Schroecken, Austria. As a visiting professor at the M. Ospanov West Kazakhstan State Medical Academy, he delivered advanced lectures and supervised doctoral research in neurodegenerative and demyelinating disorders.Prof. Michalak’s scientific portfolio demonstrates exceptional breadth and innovation. He has played a central role in multidisciplinary research initiatives, including a large Polish–Singaporean project developing computer-aided decision support systems for acute ischemic stroke therapy, and joint studies with international collaborators aimed at profiling pathological proteins in skin biopsies of patients with movement disorders. His work also encompasses biochemical and clinical signature identification for interferon therapy response in multiple sclerosis. As a contributor to the European COST Action project on mitochondrial mapping, he has examined the complex interplay of evolution, age, gender, lifestyle, and environmental factors on mitochondrial dynamics. His ongoing clinical research includes a major investigation on the influence of Cerebrolysin on blood–brain barrier integrity in acute ischemic stroke. He also collaborates with global experts on smart digital therapeutics using generative artificial intelligence and contributes to the Glioblastoma Research Group at Poznan University of Medical Sciences to advance biomarker-based early detection strategies.With more than five hundred scientific publications, a substantial cumulative impact factor, over two thousand citations, and a strong h-index, Prof. Michalak has established himself as a leading figure in contemporary neurology. His book publications, extensive consultancy roles, and active involvement in translational industry–academia partnerships further highlight his enduring impact. His research in stroke biology, neuroimmunology, neuro-oncology, and molecular biomarkers continues to shape clinical understanding and inspire innovation across the global neuroscience community.

Profile: Google Scholar

Featured Publications

Ambrosius, W., Michalak, S., & Kozubski, W., & Kalinowska, A. (n.d.). Myelin oligodendrocyte glycoprotein antibody-associated disease: Current insights into the disease pathophysiology, diagnosis and management. International Journal of Molecular Sciences, 22(1), 100.

Kazmierski, N. W. R., Michalak, S., & Wencel-Warot, A. (n.d.). Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology, 79, 160.

Jasiak-Zatonska, M., Kalinowska-Łyszczarz, A., Michalak, S., & Kozubski, W. (n.d.). The immunology of neuromyelitis optica—Current knowledge, clinical implications, controversies and future perspectives. International Journal of Molecular Sciences, 17(3), 273.

Wyciszkiewicz, A., Kalinowska-Łyszczarz, A., Nowakowski, B., Kaźmierczak, K., & Michalak, S. (n.d.). Expression of small heat shock proteins in exosomes from patients with gynecologic cancers. Scientific Reports, 9(1), 9817.

Zaborowski, M. S., Spaczynski, M., & Nowak-Markwitz, E., & Michalak, S. (n.d.). Paraneoplastic neurological syndromes associated with ovarian tumors. Journal of Cancer Research and Clinical Oncology, 71.

Adamczak-Ratajczak, A., Kupsz, J., Owecki, M., Zielonka, D., Sowinska, A., & Michalak, S., et al. (n.d.). Circadian rhythms of melatonin and cortisol in manifest Huntington’s disease and in acute cortical ischemic stroke. Journal of Physiology and Pharmacology, 68(4), 539–546.